Porton has a professional technology platform and an experienced team to provide global clients with CMC solutions for radiopharmaceutical precursors and cold drugs. We are committed to becoming the leading RDC CDMO company in China.
Contact Porton to find the pharmaceutical small molecule R&D projects that best fits your business.